Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1419
HER2amp
Luminal
Olomoucine II
CDK1
CDK
12001.147
uM
2.99980
11.99860
-0.7048 -1.0000 0.7925 0.4618
0.9453
0.5989
HCC1419
HER2amp
Luminal
Omipalisib
PI3K
PI3K
7437.086
uM
0.0020
0.00570
-0.9790 -0.8720 0.9632 1.2599
0.9859
0.4150
HCC1419
HER2amp
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
7820.011
uM
37.0910
59.21560
-0.9325 -0.9496 2.2753 0.4438
0.9589
0.6709
HCC1419
HER2amp
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
9278.011
uM
8.46420
30.49560
-0.9763 -1.0000 0.8571 0.5124
0.9604
0.5434
HCC1419
HER2amp
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
10019.12
uM
9.94530
28.0190
-0.9970 -1.0000 1.0607 0.5208
0.9649
0.4898
HCC1419
HER2amp
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
7819.075
uM
21.6960
48.16140
-0.9798 -1.0000 1.3777 0.4385
0.9760
0.5386
HCC1419
HER2amp
Luminal
Oxamflatin
HDAC
HDAC
12001.147
uM
1.24950
3.34120
-0.9989 -1.0000 1.1169 0.5960
0.8993
0.5989
HCC1419
HER2amp
Luminal
PD 98059
MEK
MAPK
12001.159
uM
inf
inf
0.4036 0.4036 0.0000 0.2866
0.4547
0.7107
HCC1419
HER2amp
Luminal
PD173074
FGFR1/3
RTK
7437.093
uM
10.27450
24.86360
-0.1998 -1.0000 1.2431 0.1989
0.8755
0.4731
HCC1419
HER2amp
Luminal
PD184352
MEK
MAPK
12001.155
uM
inf
inf
0.6410 0.6410 0.0000 0.1501
0.5358
0.5973
HCC1419
HER2amp
Luminal
PD184352
MEK
MAPK
12001.155
uM
inf
inf
0.6410 0.6410 0.0000 0.1501
0.5358
0.5973
HCC1419
HER2amp
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7437.095
uM
inf
inf
0.9403 0.9403 0.0000 0.1007
-0.0689
0.5584
HCC1419
HER2amp
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7440.095
uM
inf
inf
0.6165 0.6165 0.0000 0.2930
0.2845
0.5907
HCC1419
HER2amp
Luminal
PS-1145
IKK
NFKB
7440.065
uM
inf
inf
0.9343 0.9343 0.0000 0.1126
0.0000
0.5818
HCC1419
HER2amp
Luminal
PS-1145
IKK
NFKB
7437.065
uM
inf
inf
1.0125 1.0125 0.0000 0.0500
0.1389
0.5183
HCC1419
HER2amp
Luminal
Purvalanol A
CDK1
CDK
7437.067
uM
inf
inf
1.0500 1.0500 0.0000 -0.0473
-48.7760
0.4038
HCC1419
HER2amp
Luminal
Purvalanol A
CDK1
CDK
7440.067
uM
inf
22.81910
0.5139 0.5132 5.0000 0.0456
0.9597
0.3519
HCC1419
HER2amp
Luminal
SB-3CT
MMP2/9
MMP
12001.168
uM
inf
inf
0.7686 0.7686 0.0000 0.0542
0.4350
0.4934
HCC1419
HER2amp
Luminal
Selumetinib
MEK
MAPK
12001.155
uM
11.51560
998.95870
0.4094 -0.5983 0.1763 0.2840
0.9054
0.5973
HCC1419
HER2amp
Luminal
Sigma A6730
AKT
AKT
12001.165
uM
0.81605
3.11870
-0.9607 -1.0000 0.8194 0.5612
0.9606
0.5382
HCC1419
HER2amp
Luminal
Sirolimus
MTOR
MTOR
7819.068
uM
0.00097
0.00953
-0.9999 -0.6956 0.3814 1.1819
0.8465
0.4460
HCC1419
HER2amp
Luminal
Sirolimus
MTOR
MTOR
7818.068
uM
0.00361
0.00461
-0.2968 -0.0865 0.6554 0.8440
0.9116
0.7038
HCC1419
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7437.084
uM
inf
inf
0.9273 0.9273 0.0000 0.1333
0.0343
0.4343
HCC1419
HER2amp
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7437.067
uM
inf
inf
-0.9973 -0.9973 0.0000 0.2089
0.4251
0.4038
HCC1419
HER2amp
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7440.067
uM
12.61540
15.71650
-1.0000 -1.0000 4.9984 0.3537
0.9966
0.3519